Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01364051
First received: May 26, 2011
Last updated: August 26, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)